Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
With the rapid evolution of COVID-19, the objective was no longer relevant
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Association Clinique Thérapeutique Infantile du val de Marne | OTHER |
| Groupe de Pathologies Infectieuses Pédiatriques (GPIP) | OTHER |
| Francophone Pediatric Resuscitation and Emergency Group (GFRUP) | OTHER |
Not provided
Not provided
Not provided
Not provided
France and in particular the paris area was one of the countries most affected by the pandemic Covid19.
School closures and a generalized lockdown of the population were instituted in France from 17 March 2020 to 10 May 2020. Schools and nurseries have reopened partially since 11 May 2020. From 2 June, this reopening is more widespread. By combining the search for SARS-Cov2 viruses by PCR and micro-method serology we will be able to evaluate both the infection at a given time and also older contact with SARS-CoV2.
The temporal knowledge of the prevalence of SARS-Cov2 carriage and the serological status (IgM and IgG) after return to the community are crucial information to evaluate the speed of spread of the virus in children. This is the objective of COVILLE2, phase 2 of the COVILLE study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Children under 15 years of age in a community | Children under 15 years of age in a community : kindergarten, school, college, holiday center, etc. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RT-PCR SARS-Cov2 | Diagnostic Test | nasopharyngeal swab will be taken for detection of SARS-CoV-2 by RT-PCR |
|
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of asymptomatic children or children with mild respiratory symptoms | Proportion of asymptomatic children or children with mild respiratory symptoms (mildly-symptomatic children) with a positive SARS-Cov2 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) on rhino pharyngeal swab or/and IgM/IgG positive serology in Paris area | At inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Cov2-SARS cases by age | At inclusion | |
| Cov2-SARS cases by symptoms | At inclusion | |
| Viral load |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Children under 15 years of age in a community (kindergarten, school, college, holiday centre, etc.).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D000087123 | COVID-19 Nucleic Acid Testing |
| ID | Term |
|---|---|
| D000086742 | COVID-19 Testing |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
| Sars-Cov2 serology | Diagnostic Test | A microsample of blood will be taken for serology |
|
The viral load of children with SARS-Cov2 positive Reverse Transcriptase Polymerase Chain Reaction depending on the symptoms and the age of the patients
| At inclusion |
| Presence of anti-SARS-CoV-2 antibodies (IgM and IgG) by the rapid serological test | At inclusion |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D008919 | Investigative Techniques |